We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cosmic Rays Affect Older ICDs

By HospiMedica staff writers
Posted on 23 Oct 2005
The background levels of atmospheric ionizing radiation, commonly known as cosmic rays, can affect the memory chip in a small number of its older-generation implantable cardioverter defibrillator (ICD) products, according to St. More...
Jude Medical, Inc. (St. Paul, MN, US).

After extensive investigation, including testing at an independent nuclear laboratory, St. Jude has found that a particular static random access memory (SRAM) chip can be affected, at a low frequency rate, by background levels of atmospheric ionizing cosmic radiation. To date, the incidence of devices found to have been affected is only 60 out of 36,000. An estimated 26,000 devices remain in service.

This particular memory chip component was used in the following older generation devices: Photon DR (model V-230HV; certain serial numbers), Photon Micro VR/DR (models V-194/V-232), and Atlas VR/DR (models V-199/V-240). Although the incidence is low and there have been no serious patient injuries or deaths reported, St. Jude is taking a conservative approach in advising the medical community and regulatory agencies. In 2002, St. Jude began using a different design of the SRAM memory chip component, which does not share the same susceptibility to cosmic radiation.

"Because the incidence associated with this anomaly is low, St. Jude Medical's recommendation for monitoring at three-month intervals will be appropriate for the vast majority of patients,” said Dr. Bruce Wilkoff, director of cardiac pacing and tachyarrhythmia devices at The Cleveland Clinic and Heart Center and a member of the St. Jude medical advisory board.

A full copy of the company's advice to doctors can be found on St. Jude's website. This includes a description of the anomaly and its related risks as well as recommendations to doctors for patient monitoring.




Related Links:
Jude Medical Inc

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.